Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04761874 · ClinicalTrials.gov registry record · NA
Telestroke at Comprehensive Stroke Center During the COVID-19 Pandemic
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 296
- Enrollment target
NCT04761874 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 296 participants.
The verdict
NCT04761874, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 296 participants
- Enrollment target
Study Summary
TELEstroke to CAre for STroke Patients at a Comprehensive Stroke Center (TELECAST-CSC) during the COVID-19 pandemic is a pre-post study evaluating guideline-based acute ischemic stroke care following the implementation of inpatient telestroke at a comprehensive stroke center during the COVID-19 global pandemic. TELECAST-CSC compares two cohorts: the "in-person phase" (December 1, 2019-March 15, 2020), when all inpatient stroke team care was delivered conventionally in-person and the "telestroke phase" (March 16, 2020-June 29, 2020) when all inpatient stroke team care was delivered exclusively via telestroke as part of our healthcare system's pandemic response. We studied the following primarily clinical endpoints: diagnostic stroke evaluation, secondary stroke prevention, health screening and evaluation, stroke education, mortality, and stroke recurrence and readmission rates.
Interventions
- OTHER Telestroke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 296 participants |
| Start Date | 2019-12-01 |
| Est. Completion | 2020-09-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04761874
The ClinicalTrials.gov registry entry for NCT04761874 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 296 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Telestroke is the first listed.
NCT04761874 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04761874 about?
NCT04761874 is a clinical study titled "Telestroke at Comprehensive Stroke Center During the COVID-19 Pandemic". TELEstroke to CAre for STroke Patients at a Comprehensive Stroke Center (TELECAST-CSC) during the COVID-19 pandemic is a pre-post study evaluating guideline-based acute ischemic stroke care following the implementation of inpatient telestroke at a comprehensive stroke center during the COVID-19 glob...
What is the current status of trial NCT04761874?
This trial is currently completed. It is a NA study. The enrollment target is 296 participants. The study started on 2019-12-01. Estimated completion is 2020-09-29.
What interventions are being tested in trial NCT04761874?
The interventions under investigation include: Telestroke (OTHER).
Who is sponsoring clinical trial NCT04761874?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.